Treatment improves cognition in Down Syndrome patients

UK approves Pfizer bivalent COVID vaccine ahead of booster drive
3 September 2022
Legionnaires’ disease claims fifth life in Argentina: officials
4 September 2022

Treatment improves cognition in Down Syndrome patients

A new hormone treatment improved the cognitive function of six men with Down Syndrome by 10-30 percent, scientists said Thursday, adding the “promising” results may raise hopes of improving patients’ quality of life.

Comments are closed.